Literature DB >> 3410554

Biological effects in a chemical factory with mutagenic exposure. I. Cytogenetic and haematological parameters.

L Hagmar1, T Bellander, B Högstedt, T Hallberg, R Attewell, G Raihle, W W Au, M S Legator, F Mitelman, S Skerfving.   

Abstract

Analysis in two independent laboratories demonstrated no significant differences in chromosome aberrations or micronuclei in lymphocytes from peripheral blood between workers in a chemical factory (exposed to a mixture of chemicals, such as piperazine, low levels of ethylene oxide and formaldehyde, aromatic nitrogen compounds, and other aromatic compounds) compared to unexposed control subjects. The chemical workers had significantly higher counts of lymphocytes (3.57 vs. 2.82 X 10(9)/l; P less than 0.001), eosinophils (0.27 vs. 0.20 X 10(9)/l; P = 0.005), and basophils (0.06 vs. 0.05 X 10(9)/l; P = 0.01) than the controls. Twenty workers exposed to piperazine had higher total numbers of B-lymphocytes than control subjects.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3410554     DOI: 10.1007/bf00381392

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  22 in total

1.  Prevalence of specific IgE antibodies against piperazine in employees of a chemical plant.

Authors:  L Hagmar; H Welinder
Journal:  Int Arch Allergy Appl Immunol       Date:  1986

2.  The Hemalog D white cell differential system.

Authors:  H P Mansberg; A M Saunders; W Groner
Journal:  J Histochem Cytochem       Date:  1974-07       Impact factor: 2.479

3.  Measurement of micronuclei in lymphocytes.

Authors:  M Fenech; A A Morley
Journal:  Mutat Res       Date:  1985 Feb-Apr       Impact factor: 2.433

4.  Mortality and cancer morbidity among workers in a chemical factory.

Authors:  L Hagmar; T Bellander; V Englander; J Ranstam; R Attewell; S Skerfving
Journal:  Scand J Work Environ Health       Date:  1986-12       Impact factor: 5.024

5.  Comparison between five Nordic laboratories on scoring of human lymphocyte chromosome aberrations.

Authors:  A Brøgger; R Norum; I L Hansteen; K O Clausen; K Skårdal; F Mitelman; A M Kolnig; B Strömbeck; I Nordenson; G Andersson
Journal:  Hereditas       Date:  1984       Impact factor: 3.271

6.  [Immunological parameters in lead workers (author's transl)].

Authors:  K Yoshida; H Sakurai; T Toyama
Journal:  Sangyo Igaku       Date:  1980-11

7.  Significance of lymphocytosis in adults.

Authors:  I Chanarin; E Tidmarsh; D Harrisingh; P O Skacel
Journal:  Lancet       Date:  1984-10-20       Impact factor: 79.321

8.  The temporal relationship between behavioral and hematological effects of inhaled benzene.

Authors:  A M Dempster; H L Evans; C A Snyder
Journal:  Toxicol Appl Pharmacol       Date:  1984-10       Impact factor: 4.219

9.  Human antibodies against formaldehyde-human serum albumin conjugates or human serum albumin in individuals exposed to formaldehyde.

Authors:  R Patterson; V Pateras; L C Grammer; K E Harris
Journal:  Int Arch Allergy Appl Immunol       Date:  1986

10.  Cytogenetic, immunological, and haematological effects in workers in an ethylene oxide manufacturing plant.

Authors:  N J Van Sittert; G de Jong; M G Clare; R Davies; B J Dean; L J Wren; A S Wright
Journal:  Br J Ind Med       Date:  1985-01
View more
  2 in total

1.  Biological effects in a chemical factory with mutagenic exposure. II. Analysis of unscheduled DNA synthesis and adenosine diphosphate ribosyl transferase, epoxide hydrolase, and glutathione transferase in resting mononuclear leukocytes.

Authors:  R Pero; L Hagmar; J Seidegård; T Bellander; R Attewell; S Skerfving
Journal:  Int Arch Occup Environ Health       Date:  1988       Impact factor: 3.015

2.  Biological effects in a chemical factory with mutagenic exposure. III. Urinary mutagenicity and thioether excretion.

Authors:  L Hagmar; T Bellander; L Persson; A Holmén; R Attewell; B Högstedt; S Skerfving
Journal:  Int Arch Occup Environ Health       Date:  1988       Impact factor: 3.015

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.